Search

A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.

… Thursday, December 5, 2013 Summary A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases. Michael A. Foley, a renowned chemist and entrepreneur,

Learn about ashwagandha, an herb used for stress relief.

… Tuesday, February 1, 2022 Ashwagandha ( Withania somnifera ) is an herb that has been used in Ayurveda, the traditional Indian medical system, for more than 3,000 years. It is an adaptogen, which means it is believed to strengthen the body against physical or biological stress. Ashwagandha is used to

Memorial Sloan Kettering, one of the nation’s top cancer treatment and research institutions, is expanding its reach on Long Island with a new 114,000-square-foot freestanding cancer treatment center in Nassau County. Once complete, MSK Nassau will house the area’s most comprehensive cancer care program, centrally located and staffed by the most forward-thinking and compassionate healthcare teams whose sole focus is caring for people with cancer.

… Thursday, October 19, 2017 Memorial Sloan Kettering, one of the nation’s top cancer treatment and research institutions, is expanding its reach on Long Island with a new 114,000-square-foot freestanding cancer treatment center in Nassau County. Once complete, MSK Nassau will house the area’s most comprehensive

A simple blood test performed at age 60 can determine a man's risk of dying from prostate cancer within the next 25 years, according to a new study led by Memorial Sloan Kettering Cancer Center investigators. The study's findings suggest that regular prostate-specific antigen (PSA) screening for prostate cancer should be focused on men who receive high readings from a PSA test performed at age 60 and that men with low readings can be spared further screening.

… Wednesday, September 1, 2010 A simple blood test performed at age 60 can determine a man’s risk of dying from prostate cancer within the next 25 years, according to a new study led by Memorial Sloan Kettering Cancer Center investigators. The study’s findings suggest that regular prostate-specific antigen

Learn why surgery remains a very effective treatment for most prostate cancers.

… Wednesday, June 13, 2018 Summary Surgery can cure prostate cancer if the disease hasn’t spread outside of the prostate gland. The most common procedure is a radical prostatectomy . It can be done as traditional open surgery or in a minimally invasive approach , including robot-assisted laparoscopic surgery

In her new role, Dr. Hsu will work to diversify matriculating classes and train students to become skilled leaders as both clinicians and biomedical researchers.

… Friday, April 9, 2021 Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers , has been named director of the Tri-Institutional M.D.-Ph.D. Program , a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial

When this feathered patient found her way into a New York laboratory in 1909, she changed the course of cancer science.

… Wednesday, December 27, 2017 Summary Nobel prizes aren’t awarded posthumously — or to chickens. But a case could be made that we owe our greatest cancer discoveries to one such unassuming bird. Peyton Rous wasn’t expecting a chicken to show up in his laboratory one day in 1909. But there she was, a barred

Learn how developmental biologists at MSK solved a decades-old cellular mystery. Their findings will have an immediate and lasting impact on the understanding and treatment of ciliopathies, which cause a host of medical problems and affect 1 in 2,000 people worldwide.

… Thursday, August 28, 2025 Some might say it looks like a finger. Others might see a worm. Scientists in the field often liken it to an antenna. The technical name is primary cilium. This slender, microscopic appendage juts out from the surface of most cells in the human body — and yet for many years,

Learn about a new multiple myeloma drug that can stop the disease after other treatments have failed.

… Thursday, August 24, 2023 There is good news about  multiple myeloma , a rare blood cancer that can be difficult to treat. This month, the FDA granted accelerated approval to a drug, elranatamab (Elrexfio™) for resistant forms of the disease.  “Widespread availability of elranatamab could help improve

MSK's Dr. Larry Norton, a national breast cancer expert, discusses how artificial intelligence is helping doctors.

… Monday, June 10, 2024 Artificial intelligence (AI) technology has been in the spotlight in recent months as AI chatbots and image generators have become widespread, leading to renewed conversations about the technology’s role in medicine. One of AI’s most immediate applications for patient care is to